MassDevice9h
FDA approves Medtronic’s Affera cardiac mapping and ablation system and Sphere-9 catheter
Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...
Medtronic’s Affera ablation system granted FDA approval
Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...
Medtronic Gets FDA Approval for Affera Technology
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
medtechdive9d
Medtronic to evaluate Affera in ventricular tachycardia
The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...
Le Lézard10h
A new paradigm in electrophysiology: Medtronic receives FDA approval of Afferatm Mapping and Ablation System and Sphere-9tm Catheter
Highly anticipated by electrophysiologists for its innovation and demonstrated safety and efficacy as well as improved ...
GlobalData on MSN10d
FDA approves Medtronic’s Affera system for VT treatment study
The study aims to assess the Catheter and Affera system in patients who have ventricular tachycardia (VT) due to scarring ...
MassDevice13d
FDA says Medtronic can study Affera pulsed field ablation system for treating ventricular tachycardia
Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...
BioWorld7d
FDA OKs study of Medtronic’s Affera in ventricular tachycardia
Medtronic plc received U.S. FDA approval to undertake an early feasibility study of its dual-energy Affera cardiac ablation system in sustained ventricular tachycardia. Affera combines both ...